We are live on ! Find out more
PCM

Price Capital Management Portfolio holdings

AUM $7.05M
1-Year Est. Return 47.39%
This Fund
S&P 500
This Quarter Est. Return
+30.95%
1 Year Est. Return
+47.39%
3 Year Est. Return
+124.26%
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
Cap. Flow
+$102M
Cap. Flow %
89.55%
Top 10 Hldgs %
32.61%
Holding
64
New
64
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Technology 14.12%
3 Consumer Discretionary 12.55%
4 Industrials 11.83%
5 Financials 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
$1.55M 1.37%
+86,705
New +$1.4M
BCC icon
27
Boise Cascade
BCC
$2.94B
$1.55M 1.37%
+41,760
New +$1.44M
NUVA
28
DELISTED
NuVasive, Inc.
NUVA
$1.55M 1.37%
+32,879
New +$1.37M
SONC
29
DELISTED
Sonic Corp
SONC
$1.54M 1.36%
+56,648
New +$1.44M
BJRI icon
30
BJ's Restaurants
BJRI
$1.49B
$1.54M 1.36%
+30,678
New +$1.35M
SNBR
31
DELISTED
Sleep Number
SNBR
$1.53M 1.35%
+56,561
New +$1.41M
ACHC icon
32
Acadia Healthcare
ACHC
$2.86B
$1.51M 1.33%
+24,722
New +$1.44M
TYL icon
33
Tyler Technologies
TYL
$12.5B
$1.51M 1.33%
+13,761
New +$1.45M
WST icon
34
West Pharmaceutical
WST
$24.5B
$1.5M 1.32%
+28,163
New +$1.41M
STE icon
35
Steris
STE
$22.6B
$1.47M 1.3%
+22,728
New +$1.4M
ELLI
36
DELISTED
Ellie Mae Inc
ELLI
$1.47M 1.3%
+36,497
New +$1.41M
EPAM icon
37
EPAM Systems
EPAM
$4.86B
$1.45M 1.28%
+30,297
New +$1.43M
IONS icon
38
Ionis Pharmaceuticals
IONS
$9.06B
$1.35M 1.19%
+21,841
New +$1.08M
MACK
39
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.33M 1.18%
+15,004
New +$1.09M
PTCT icon
40
PTC Therapeutics
PTCT
$5.91B
$1.31M 1.15%
+25,218
New +$1.11M
AMAG
41
DELISTED
AMAG Pharmaceuticals
AMAG
$1.3M 1.15%
+30,570
New +$1.1M
NBIX icon
42
Neurocrine Biosciences
NBIX
$16.2B
$1.29M 1.14%
+57,840
New +$1.1M
AGIO icon
43
Agios Pharmaceuticals
AGIO
$1.91B
$1.29M 1.13%
+11,475
New +$1.02M
NVAX icon
44
Novavax
NVAX
$1.27B
$1.27M 1.12%
+10,694
New +$1.12M
LUMO
45
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.27M 1.12%
+3,543
New +$1.05M
ENTA icon
46
Enanta Pharmaceuticals
ENTA
$388M
$1.26M 1.11%
+24,807
New +$1.11M
EXAS
47
DELISTED
Exact Sciences
EXAS
$1.24M 1.09%
+45,180
New +$1.1M
INFN
48
DELISTED
Infinera Corporation Common Stock
INFN
$1.22M 1.08%
+83,148
New +$1.1M
FRGI
49
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$1.22M 1.08%
+20,064
New +$1.11M
SPNC
50
DELISTED
Spectranetics Corp
SPNC
$1.22M 1.07%
+35,156
New +$1.1M

Similar funds

Price Capital Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Price Capital Management, which disclosed 64 positions worth $113M. Its ten largest holdings account for 33% of the portfolio.

Its largest position is State Street Consumer Staples Select Sector SPDR ETF: 254,560 shares worth $12.3M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Consumer Discretionary.

  • Price Capital Management's largest Q4 2014 buy was State Street Consumer Staples Select Sector SPDR ETF: 254,560 shares worth $12.3M.
  • Price Capital Management's ten largest holdings make up 33% of its $113M portfolio in Q4 2014.
  • Price Capital Management disclosed 64 positions in Q4 2014, its first 13F filing on record.

Based on Price Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.